Transforming Healthcare: Key Trends in South African Healthtech

By Crystal Lubbe

November 26, 2024

South Africa healthcare technology

The South Africa healthcare technology sector is experiencing significant growth, driven by a combination of local innovation and international collaboration. Companies like CFAO Healthcare are making strategic investments, emphasising the sector’s expanding opportunities. CFAO Healthcare’s acquisition of Sanofi’s South African Consumer Healthcare business emphasises the increasing interest in healthcare technology within the region.

1. Expansion and Investments

CFAO Healthcare are actively moving into the South African market, which indicates a growing interest in the region’s healthcare technology sector. The acquisition of Sanofi’s South African Consumer Healthcare business by CFAO Healthcare highlights this trend.

2. Digital Health Innovations

South African healthtech startups, such as RecoMed, are securing significant funding to enhance digital healthcare services. RecoMed’s emphasis on streamlining appointment bookings and its specialisation in breast cancer care reflect the innovative approaches being embraced in the healthcare technology landscape.

3. Government Initiatives and Masterplans

The South African government has introduced a Medical Technology Masterplan aimed at enhancing the growth of the healthcare technology sector. This initiative seeks to improve regulatory frameworks, market growth, technology production, and research innovation, which are vital for developing local healthcare technologies.

4. Vaccine Manufacturing and Health Security

To enhance health security, efforts to improve vaccine manufacturing capabilities in South Africa are underway. Partnerships between Biovac and various development institutions are part of a broader strategy to increase local production of vaccines and reduce reliance on imports.

5. International Collaborations and Funding

There is a notable influx of international funding and partnerships in the South African healthcare technology sector. The Transform Health Fund, a $50 million pan-African initiative, is providing impact investments to health innovators across Sub-Saharan Africa, enhancing the development of healthcare technology in South Africa.

Implications for Healthcare Technology Companies

  • Market Growth: Increased investments and market expansion in South Africa reveal rising demand for healthcare technologies and business opportunities.
  • Innovation: Companies like RecoMed and EMGuidance show the potential of digital health to transform healthcare outcomes.
  • Regulatory Support: Government initiatives, such as the Medical Technology Masterplan, encourage investment and innovation in healthcare technology.
  • Global Partnerships: Collaborations with global organisations, like Eisai and Biovac, emphasize the importance of international partnerships in advancing healthcare.

These trends suggest significant growth for South Africa’s healthcare technology sector, offering opportunities to shape its future.

Reference url

Recent Posts

real-world evidence Portugal
Enhancing Health Technology Assessment Through Real-World Evidence in Portugal

By João L. Carapinha

June 17, 2026

Real-world evidence Portugal has moved from supplementary tool to statutory requirement under Decree-Law 118/2026, which compels national health systems to share interoperable data so that promised outcomes can be verified after medicines and devices reach patients. The legislation converts one-t...
Portuguese HTA Regulation
Integrating the Portuguese HTA Regulation into National Health Systems

By João L. Carapinha

June 17, 2026

The Portuguese HTA Regulation has delivered the most significant overhaul of the National System for Health Technology Assessment (SiNATS) since its creation in 2015. Published through Decreto-Lei n.º 118/2026, ...
Dapagliflozin Pricing Framework
Regulatory Insights on Dapagliflozin Pricing Framework

By João L. Carapinha

June 17, 2026

Portugal’s Dapagliflozin Pricing Framework establishes a single reference price for all reimbursed 10 mg dapagliflozin tablets by creating homogeneous group GH1326. According to INFARMED’s latest notificat...